Celiac & Gluten Sensitivity; blood spot
Celiac disease (CD) is often undiagnosed and is caused in genetically predisposed individuals by abnormal intestinal permeability and abnormal immune response to gluten, a protein complex found in wheat, barley, spelt and rye. The inflammatory autoimmune response damages the lining of the small bowel and is associated with diarrhea, bloating, fatigue, nutritional deficiencies, and systemic autoimmune conditions. Gluten sensitivity can cause similar symptoms but without the same level of tissue damage. The Celiac & Gluten Sensitivity profile from Doctor’s Data helps differentiate between CD and gluten sensitivity by evaluating the serum titers of IgA and IgG for deamidated gliadin peptide and gliadin.
[ LEARN MORE]
- Patients who have persistent skin conditions (rash) or ataxia, idiopathic neurological conditions, autoimmune arthritis/ thyroiditis, unexplained weight loss or persistent gastrointestinal symptoms that are not associated with enteropathogens
- Symptomatic individuals that have tested positive for the HLA DQ2/DQ8 genotypes
- Patients with symptoms or symptom exacerbation with dietary gluten or re-introduction of gluten after a trial elimination of gluten
- Individuals that have a first degree relative with a diagnosis of CD
- Any child with a history of 3 or more antibiotic-treated cases of gastroenteritis while less than 6 months of age
- Patients on a gluten-inclusive diet who have Type I diabetes, Multiple Sclerosis or schizophrenia
- Individuals on a gluten-inclusive diet who have other laboratory evidence that may be associated with CD:
- Elevated liver function tests
- Bone demineralization
- Evidence of impaired absorption of fat-soluble vitamins, iron, B12 or folic acid
3 to 5 days
Note: Turnaround times on results are an estimate and are not guaranteed. The lab may need additional time due to holidays, confirmation/repeat testing, etc. You can contact us to discuss when your results should be ready.
Click any analyte name for additional clinical information, including reference ranges, specimen collection, stability and rejection criteria.
List price applies when filing with insurance or Medicare, or when billing a patient directly.
Prompt payment pricing applies when billing to a physician account or prepayment is received with the test.
Doctor's Data offers profiles containing multiple analytes. *Multiple analytes may be billed under a single CPT code. Many analytes can be ordered individually. Pricing may vary. Click on a specific analyte for more information or read our detailed billing and payment policies.
The CPT codes listed on our website are for informational purposes only. This information is our interpretation of CPT coding requirements and may not necessarily be correct. You are advised to consult the CPT Coding Manual published by the American Medical Association. Doctor's Data, Inc. takes no responsibility for billing errors due to your use of any CPT information from our website.
Sign in at the top of any page to view pricing and order tests. Or click here to create an account. You may also contact us for assistance placing an order.
The Celiac & Gluten Sensitivity profile from Doctor’s Data helps differentiate between CD and gluten sensitivity by evaluating the serum titers of IgA and IgG for deamidated gliadin peptide and gliadin.
Celiac disease (CD) is often undiagnosed and is caused in genetically predisposed individuals by abnormal intestinal permeability and abnormal immune response to gluten, a protein complex found in wheat, barley, spelt and rye. The inflammatory autoimmune response is associated with extreme damage to the lining of the small bowel and is associated with diarrhea, bloating, fatigue, nutritional deficiencies, and systemic autoimmune conditions. Although most commonly diagnosed in children, CD is often not expressed until later in life (delayed onset). It has been hypothesized that a gradual or abrupt change in the gastrointestinal microbiome may be responsible for delayed on set. Non-Celiac gluten sensitivity (NCGS) can cause similar symptoms but without the same level of intestinal epithelial tissue damage.
Antibody tests that indicate possible CD and NCGS will only be accurate if the patient is on a gluten-inclusive diet. The test is also useful for monitoring adherence to a gluten-free diet.
CD may result in a variety of gastrointestinal (GI) and “extra-intestinal” symptoms. Common symptoms associated with CD include:
- Weight loss
- Abdominal pain
- Iron deficiency anemia
- Rashes and skin problems
- Peripheral neuropathy or ataxia
- Autoimmune arthritis or neurological conditions
- Failure to thrive (infants)
- Bone disease or loss of bone density
- Hormone and fertility problems
- Abnormal liver function tests
CD is also associated with other clinical disorders including thyroiditis, type I diabetes mellitus, Down syndrome, and IgA deficiency. Patients diagnosed with CD must remain on a gluten-free diet for life and avoid all gluten containing foods and grains (wheat, rye, spelt, barley). This test is clinically useful for monitoring patient adherence to a gluten-free diet. Gluten is present in almost all processed foods and many beverages. A complete list of foods containing gluten may be found at www.doctorsdata.com under 'Hidden Sources of Ingredients'.
Non-Celiac Gluten Sensitivity (NCGS)
Individuals with NCGS are often spared the intestinal damage common in Celiac patients, but suffer from abdominal pain, bloating, diarrhea, constipation, and many “extra-intestinal” symptoms such as “foggy mind”, depression, ADHD-like behavior, headaches, bone or joint pain, and chronic fatigue when they have gluten in their diet. There are many antigenic triggers (epitopes) in the gluten protein complex that have cytotoxic, immunomodulatory, and gut permeating properties.
Immune cells activated in the sub-endothelial space in the gut circulate throughout the body. Up to 50% of NCGS patients may only test positive for IgG anti-gliadin antibodies when on a gluten-inclusive diet.
American Association for Clinical Chemistry (2011) Celiac Disease Tests http://labtestsonline.org/
accessed 15 May 2014.
Hischenhuber, C; Crevel, R; Jarry, B; Mäki, M; Moneret-Vautrin, D A et al. (2006)
Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease.
Alimentary pharmacology & therapeutics vol. 23 (5) p. 559-75
Nelsen, David A. JR., M.D., M.S., (2002) Gluten-Sensitive Enteropathy (Celiac Disease): More Common Than You Think. Am Fam Physician. 2002 Dec 15;66(12):2259-2266.
Pietzak, Michelle (2012) Celiac Disease, Wheat Allergy, and Gluten Sensitivity: When Gluten Free Is Not a Fad
. JPEN J Parenter Enteral Nutr vol. 36 (1_suppl) p. 68S-75
Rubio-Tapia, Alberto; Hill, Ivor D; Kelly, Ciarán P; Calderwood, Audrey H; Murray, Joseph A (2013) ACG clinical guidelines: diagnosis and management of celiac disease
. The American journal of gastroenterology vol. 108 (5) p. 656-76; quiz 677
Sapone, Anna; Lammers, Karen; Casolaro, Vincenzo; Cammarota, Marcella; Giuliano, Maria et al. (2011) Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity
. BMC Medicine vol. 9 (1) p. 23
The NIDDK National Digestive Diseases Information Clearinghouse (NDDIC) (2012) Celiac Disease. http://digestive.niddk.nih.gov/ddiseases/pubs/celiac/#why
accessed 04 June 2014
Wang, Ning; Truedsson, Lennart; Elvin, Kerstin; Andersson, Bengt A; Rönnelid, Johan et al. (2014) Serological assessment for celiac disease in IgA deficient adults
. PloS one vol. 9 (4)
Fasano, Alessio. Surprises from Celiac Disease. (2009) Scientific American vol. 301 August pp. 54-61